| SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS |
SCHEDULE
OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL
STATEMENTS
Consolidated
Balance Sheet
(in
thousands)
As
of December 31, 2023
| | |
As Previously | | |
Revision | | |
As | |
| | |
Reported | | |
Adjustments | | |
Revised | |
| Assets | |
| | | |
| | | |
| | |
| Current Assets: | |
| | | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 121,691 | | |
$ | (22,970 | ) | |
$ | 98,721 | |
| Marketable securities | |
$ | - | | |
$ | 22,970 | | |
$ | 22,970 | |
| Total Current Assets | |
$ | 221,734 | | |
$ | - | | |
$ | 221,734 | |
| Total Assets | |
$ | 428,519 | | |
$ | - | | |
$ | 428,519 | |
Consolidated
Statement of Cash Flows
(in
thousands)
For
The Year Ended December 31, 2023
| | |
As Previously | | |
Revision | | |
As | |
| | |
Reported | | |
Adjustments | | |
Revised | |
| Cash Flows From Investing Activities: | |
| | | |
| | | |
| | |
| Proceeds from sale of marketable securities | |
$ | - | | |
$ | 16,442 | | |
$ | 16,442 | |
| Net Cash Used In Investing Activities | |
$ | (13,240 | ) | |
$ | (22,970 | ) | |
$ | (36,210 | ) |
| Net Increase In Cash and Cash Equivalents and Restricted Cash | |
$ | 85,137 | | |
$ | (22,970 | ) | |
$ | 62,167 | |
| Cash and Cash Equivalents and Restricted Cash - Beginning of Year | |
$ | 36,633 | | |
$ | - | | |
$ | 36,633 | |
| Cash and Cash Equivalents and Restricted Cash - End of Year | |
$ | 121,770 | | |
$ | (22,970 | ) | |
$ | 98,800 | |
| | |
| | | |
| | | |
| | |
| Cash and cash equivalents and restricted cash consisted of the following: | |
| | | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 121,691 | | |
$ | (22,970 | ) | |
$ | 98,721 | |
| Restricted cash | |
$ | 79 | | |
$ | - | | |
$ | 79 | |
| Cash and Cash Equivalents
and Restricted Cash - End of Year | |
$ | 121,770 | | |
$ | (22,970 | ) | |
$ | 98,800 | |
|